News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
635,972 Results
Type
Article (52440)
Company Profile (176)
Press Release (583356)
Multimedia
Podcasts (74)
Webinars (8)
Section
Business (179260)
Career Advice (2716)
Deals (33033)
Drug Delivery (112)
Drug Development (78901)
Employer Resources (166)
FDA (16442)
Job Trends (15213)
News (316475)
Policy (32324)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (7)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2840)
Accelerated approval (6)
Adcomms (28)
Allergies (87)
Alliances (46353)
ALS (91)
Alzheimer's disease (1419)
Antibody-drug conjugate (ADC) (132)
Approvals (16409)
Artificial intelligence (256)
Autoimmune disease (24)
Automation (14)
Bankruptcy (340)
Best Places to Work (11573)
BIOSECURE Act (18)
Biosimilars (115)
Biotechnology (122)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (272)
Cancer (2120)
Cardiovascular disease (184)
Career advice (2287)
Career pathing (32)
CAR-T (155)
Cell therapy (422)
Cervical cancer (19)
Clinical research (64255)
Collaboration (818)
Compensation (224)
Complete response letters (30)
COVID-19 (2820)
CRISPR (42)
C-suite (229)
Cystic fibrosis (106)
Data (2027)
Decentralized trials (2)
Denatured (19)
Depression (50)
Diabetes (269)
Diagnostics (6404)
Digital health (19)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (119)
Drug pricing (110)
Drug shortages (29)
Duchenne muscular dystrophy (96)
Earnings (66903)
Editorial (41)
Employer branding (22)
Employer resources (146)
Events (85439)
Executive appointments (684)
FDA (17616)
Featured Employer (37)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (714)
Gene editing (106)
Generative AI (25)
Gene therapy (310)
GLP-1 (792)
Government (4718)
Grass and pollen (5)
Guidances (50)
Healthcare (18739)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (128)
Indications (26)
Infectious disease (2972)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (93)
Interviews (509)
IPO (14705)
IRA (42)
Job creations (4031)
Job search strategy (1911)
Kidney cancer (10)
Labor market (29)
Layoffs (522)
Leadership (21)
Legal (7343)
Liver cancer (78)
Lung cancer (311)
Lymphoma (138)
Machine learning (4)
Management (59)
Manufacturing (285)
MASH (64)
Medical device (13230)
Medtech (13235)
Mergers & acquisitions (18776)
Metabolic disorders (712)
Multiple sclerosis (78)
NASH (21)
Neurodegenerative disease (103)
Neuropsychiatric disorders (28)
Neuroscience (1957)
NextGen: Class of 2025 (6761)
Non-profit (4848)
Northern California (2340)
Now hiring (30)
Obesity (388)
Opinion (242)
Ovarian cancer (74)
Pain (89)
Pancreatic cancer (78)
Parkinson's disease (148)
Partnered (19)
Patents (206)
Patient recruitment (99)
Peanut (50)
People (54234)
Pharmaceutical (31)
Pharmacy benefit managers (20)
Phase I (19965)
Phase II (28063)
Phase III (21533)
Pipeline (1114)
Policy (136)
Postmarket research (2562)
Preclinical (7739)
Press Release (63)
Prostate cancer (97)
Psychedelics (34)
Radiopharmaceuticals (229)
Rare diseases (393)
Real estate (5689)
Recruiting (69)
Regulatory (22360)
Reports (35)
Research institute (2507)
Resumes & cover letters (414)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (74)
Series A (130)
Series B (83)
Service/supplier (9)
Sickle cell disease (55)
Southern California (2116)
Special edition (16)
Spinal muscular atrophy (156)
Sponsored (25)
Startups (3562)
State (1)
Stomach cancer (15)
Supply chain (66)
Tariffs (19)
The Weekly (53)
United States (19816)
Vaccines (767)
Venture capitalists (39)
Weight loss (274)
Women's health (31)
Worklife (19)
Date
Today (4)
Last 7 days (445)
Last 30 days (2220)
Last 365 days (30996)
2025 (8258)
2024 (33073)
2023 (37837)
2022 (48493)
2021 (52902)
2020 (52608)
2019 (46512)
2018 (35736)
2017 (32329)
2016 (31338)
2015 (35415)
2014 (27071)
2013 (22252)
2012 (23986)
2011 (24759)
2010 (22068)
Location
Africa (927)
Alabama (53)
Alaska (7)
Arizona (169)
Arkansas (14)
Asia (37857)
Australia (6540)
California (5439)
Canada (1644)
China (462)
Colorado (246)
Connecticut (246)
Delaware (107)
Europe (87038)
Florida (754)
Georgia (179)
Hawaii (1)
Idaho (59)
Illinois (495)
India (25)
Indiana (290)
Iowa (8)
Japan (140)
Kansas (94)
Kentucky (25)
Louisiana (10)
Maine (68)
Maryland (794)
Massachusetts (3589)
Michigan (207)
Minnesota (341)
Mississippi (2)
Missouri (80)
Montana (26)
Nebraska (25)
Nevada (50)
New Hampshire (68)
New Jersey (1443)
New Mexico (30)
New York (1491)
North Carolina (887)
North Dakota (8)
Northern California (2340)
Ohio (178)
Oklahoma (13)
Oregon (33)
Pennsylvania (1109)
Puerto Rico (10)
Rhode Island (26)
South America (1282)
South Carolina (18)
South Dakota (1)
Southern California (2116)
Tennessee (93)
Texas (744)
Utah (179)
Virginia (132)
Washington D.C. (59)
Washington State (495)
West Virginia (3)
Wisconsin (47)
635,972 Results for "limflow sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Inari Medical Closes Acquisition of LimFlow
Inari Medical, Inc. announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 15, 2023
·
3 min read
Deals
LimFlow Announces Agreement to Be Acquired by Inari Medical
LimFlow SA announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
November 1, 2023
·
3 min read
Deals
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
Inari Medical, Inc. announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 1, 2023
·
9 min read
FDA
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
LimFlow SA announced today that the U.S. Food and Drug Administration (FDA) has approved the LimFlow System to help people with CLTI who have no other suitable endovascular or surgical treatment options and are facing major amputation.
September 12, 2023
·
5 min read
Landmark New England Journal of Medicine Publication Reports Positive Results From PROMISE II Pivotal Trial Showing that LimFlow System Saves Most Patients with End-stage Peripheral Artery Disease From Major Amputation
LimFlow SA announced that results from the PROMISE II U.S. pivotal trial were published.
March 30, 2023
·
6 min read
Business
LimFlow Appoints Jenny Gaffney as Vice President, Health Economics and Reimbursement
LimFlow SA today announced the appointment of Jenny Gaffney as Vice President, Health Economics and Reimbursement.
August 23, 2022
·
3 min read
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
LimFlow Raises $40 Million (€36 Million) in Series D Financing
LimFlow SA today announced it has closed a $40 million (€36 million) oversubscribed Series D financing round.
April 5, 2022
·
4 min read
1 of 63,598
Next
